Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
INNOVENT BIO Clarifies Operation Still Normal, Sees 2025 as Pivotal Yr for Substantial Biz Growth
Recommend 6 Positive 14 Negative 2 |
||||
|
||||
|
INNOVENT BIO (01801.HK) has issued a statement to clarify the unusual price and trading volume movements of its shares. It confirmed that its business and operation remained unchanged. Looking ahead, the company believed that 2025 would be a pivotal year for substantial business growth and concrete steps in global innovation. On the last trading day (16th), INNOVENT BIO closed at $30, down $3.45 or 10.31%, on a volume of 43.2 million shares and a turnover of RMB1.317 billion. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
